(Q42509468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

7 February 2020

main subject

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Luigi Minerba

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

D Romualdi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Di Florio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

S Sanna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

V Tagliaferri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Gambineri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

F Tomassoni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

R Pasquali

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Lanzone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

10 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

3057-3066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22786777%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin directly inhibits androgen production in human thecal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Insulin and polycystic ovary syndrome: a new look at an old subject.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin has direct effects on human ovarian steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Polycystic ovary syndrome: syndrome XX?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Genetic variants of the organic cation transporter 2 influence the disposition of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDES262